Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid

The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics

Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development

Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services

Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO

Move to accelerate cancer care expansion across India

NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair

Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage

UICC report flags air pollution as major multi-cancer risk

The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation

AWS unveils Amazon Bio Discovery to accelerate drug design with AI

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania